BMS-639623 is a CCR3 antagonist with a picomolar inhibitory effect on eosinophilic chemotaxis and can be used in the treatment of asthma.

675122-44-8

C25H32FN7O2

481.57

CHEMBL399495;PON9OFP69G;BMS 639623;UNII-PON9OFP69G

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years